Lora Black has professional experience practicing as an Oncology Nurse for over fifteen years, twelve of which focused around oncology clinical research. She has held various positions within the clinical research department at Sanford during her tenure, and currently serves as Senior Director. As Senior Director, she has oversight and responsibility for clinical research performed across the Sanford footprint, which covers six states in the rural Midwest and far-reaching collaborations with national and international health care entities. She provides leadership and strategic vision for clinical research team as well as day-to-day guidance of operations. She holds certifications as an Oncology Certified Nurse and Certified Clinical Research Professional. She completed an MPH from Creighton University with a concentration in Health Policy and Ethics. She is also a Faculty Member for the biomedical ethics program at the South Dakota Sanford School of Medicine.

Although 85% of cancer patients in the United States are treated within the community-based setting, opportunities for advanced treatment options via clinical trials are lacking. The National Comprehensive Cancer Network (NCCN) Guidelines state “NCCN believes that the best management for any patient with cancer is a clinical trial. Participation in clinical trials is especially encouraged” (NCCN 2018). To address the need for clinical trials in the rural communities served by Sanford Health, efforts described here were employed over the last five years to develop and maintain a robust portfolio of clinical trials for physicians to utilize as innovative treatment options. Successful approaches to cultivating an oncology clinical research program include (but are not limited to): developing a relationship with clinical operations, administration, physicians, support staff, research staff, and external partners. Formal trial selection through a protocol review and monitoring committee ensures physician engagement in the process of building a trial portfolio, and assists the study team in identifying feasibility concerns at the outset of considering the trial at the site. Furthermore, leveraging efficiencies of an integrated health care system are critical for study-start up, data collection, and subject coordination – all of which contribute to a site’s ongoing ability to remain attractive for future site selection. In addition, utilizing existing infrastructure for patient care management to screen eligible patients for trial significantly increases institutional enrollment percentages. The complexities of a clinical trial program focused in oncology are wide and varied. However, building a program is not impossible as long as the appropriate commitment, strategy, and dedication of resources are applied.

Janett Jalil obtained her Medical Doctor degree at the Medical Sciences Institute Carlos J. Finlay in Camaguey Cuba. She completed her residency program in Internal Medicine at the same university three years later. She is the Owner and Director of School of Clinical Research USA, LLC, a clinical research site founded in 2010 to conduct industry sponsored clinical research trials and to promote community awareness about clinical research. Most recently, she was invited as an International Jury Member for the European division of the Videomed 2016 medical education media competition.

Telemedicine has changed the face of medicine in the latest years. The number of physicians applying this technology to facilitate

patient access to their services from anywhere around the globe, at any time of the day, is steadily increasing. The potential

applications of this technology in clinical trials are an exciting prospect. Although some major pharmaceutical companies and large

research centers have spearheaded the implementation of telemedicine platforms as part of their common practices, its use has not spread to smaller settings. The potential benefits derived from expanding the use of telemedicine in clinical trials cover critical areas such as safety reporting, data quality, data review and monitoring, among others. At the site level, this means an improved patient experience, and minimal-error, real time data reporting to sponsors.

W O Chu has graduated from the Department of Pharmacy Taipei Medical University (TMU) and Institute of Biomedical Engineering National Yang Ming University. She is an Adjunct Instructor at TMU and a Pharmacist in Taipei City Hospital, Department of Pharmacy. She has published more than 10 papers in the journal of Taiwan, 2 posters in International Pharmaceutical Federation (FIP), 1 poster in European Association of Hospital Pharmacists (EAHP), and got best poster award in the international pharma and clinical pharmacy congress.

Moawiah Khatatbeh has his expertise in public health and epidemiology and passion in improving the health and wellbeing. His philosophy is that our health is within the reach of our hands. In other words, most of health problems are avoidable. He has built this philosophy after years of experience in research, evaluation, and teaching both in hospitals and education institutions.

Zaid Altaany has completed his PhD in 2013 from Canada. After his PhD he perused his postdoctoral training in the Department of Biochemistry at Schulich School ofMedicine & Dentistry, Western University, Canada. After completion of his postdoctoral training he was appointed as an Assistant professor in the Department of Medical Laboratory Sciences at Al Balqa University for one year. He was then appointed in 2016 as an Assistant Professor in the Department of Medical Sciences at the Faculty of Medicine at Yarmouk University in Jordan until know. His interests are focused on gasotransmitters, including hydrogen sulfide and nitric oxide and their impact on human health and cell signaling.

y of Alberta (PhD in basic medical sciences). I was supervised by Prof. Gary Lopaschuk and our lab is interested in heart and metabolic diseases such as obesity and diabetes. Currently, i am assistant professor in faculty of pharmacy. I teach courses related to Physiology and Pathophysiology.

Kaushal Kapadia is an expert clinical research professional with an experience of more than 10 years in clinical research operations. Apart from that an author for the book titled “Perspective on Clinical Research, India” also a best poster award winner at an international conference organized by OMICS in the year 2015 organized in Florida,

USA.

Sarnai Arlud has a passion for the mind body interaction. She is focused on evaluating the use of Mongolian mind body interactive psychotherapy in insomnia and psoriasis, and also helping the group assess Mongolian mind body interactive psychotherapy in esophagus cancer, gastric cancer, ulcerative colitis, hyperthyroidism, rheumatoid arthritis, fatty liver, depression, anxiety, hyperplasia of mammary glands, chronic fatigue syndrome, and anti-aging. In addition to this, she is working at understanding the molecular mechanism of Mongolian mind body interactive psychotherapy in psoriasis and its possible function of symptom reaction

Amer Hayat Khan joined Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, as a Senior Lecturer. He is involved in teaching (Undergraduate Pharmacy & Master in Clinical Pharmacy i.e. M.Pharm) and hospital visits regarding pharmacy students clerkships. He is also involved in research supervision of PhD’s, Master’s either in Pharmacy and/or Medical students’ research project, community activities, university services etc. He is a Journal Editor and a Reviewer. He shared his skill and research on international platform as a resource person for workshop or as an invited speaker in a conference. In addition to this, he is a Visiting Staff for Chronic Kidney Disease & Resource Center, Hospital USM. Furthermore, he is also acting as a Program Consultant and Visiting Staff for Pharmacy Department at Quaid-e-Azam University, Islamabad, Pakistan. He has supervised 5 PhD’s and 19 Master’s students by research and/or course work research project, while 6 researchers are reaching to defence, whereas 5 are under active supervision. All research projects are published and or publishing in indexed journal.

Abdeen Mustafa Omer is an Associate Researcher at Occupational Health Administration, Ministry of Health and Social Welfare, Khartoum, Sudan. He has been listed in the book WHO’S WHO in the World 2005, 2006, 2007 and 2010. He has published over 300 papers in peer-reviewed journals, 200 review articles, 7 books and 150

chapters in books.

Clérin E is a Research Engineer and her main expertise is in the fields of animal experimentation, gene therapy, tissue culture, immunohistochemistry and biochemistry. She is managing the research activities of the team. She has developed an automated counting platform at the institute of vision, e-conome to measure cone density over the whole mouse retinal surface. This system, developed as a part of the translational research projects on RdCVF was used in the majority of the team projects in a total of six publications. Also, her main mission is focused currently on this preclinical research project and to assume daily the organization, the follow-up and the feasibility of the totality of the experiment.